Supporting National Breast Awareness Cancer Month with Prevention
National Breast Cancer Awareness Month (NBCAM) is an annual campaign to increase attention and support of the disease educating about prevention and early detection. This commemorative date was established in 1985 as a partnership between the American Cancer Society and the pharmaceutical division of Imperial Chemical Industries (now part of AstraZeneca, a leading manufacturer of oncology drugs).
Through the distribution of promotional materials, brochures, advertisements, public service spots, and other educational aids, the Breast Cancer Consortium program encouraged routine self-breast exams and annual mammograms.
A report on statistics by Breast Cancer Statistics claims that this disease is the most common cancer diagnosed among US women (excluding skin cancers) and is the second leading cause of cancer death among women after lung cancer.
According to Breastcancer.org, the latest statistics show that in 2018:
- Approximately 266,120 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 63,960 new cases of non-invasive (in situ) breast cancer.
- About 40,920 women in the U.S. are expected to die in 2018 from breast cancer, though death rates have been decreasing since 1989.
- As of January 2018, there are more than 3.1 million women with a history of breast cancer in the U.S (including women currently being treated and those who have finished treatment).
- About 2,550 new cases of invasive breast cancer are expected to be diagnosed in men in 2018. A man’s lifetime risk of breast cancer is about 1 in 1,000.
CONEXIA has a Risk Management module in which individuals health, illness antecedents and their pre-existent risk factors are considered at the time of enrollment in their medical coverage. This tool, designed according to medical guidelines, facilitates the identification and adherence to health care programs of patients at risk.
It is possible to group individuals by gender, age group and risk. Having clearly identified the group that will be the focus of attention, will optimize the provision of adequate services and procedures to favor the early detection of breast cancer.
Do you have questions about our solutions for Healthcare? Contact us and discover more about our customized solutions for Healthcare organizations:
Explore our Solutions for Healthcare Explore our Solutions for Workers' Comp